Accelerate Diagnostics Inc reports results for the quarter ended in December - Earnings Summary

Accelerate Diagnostics

29/03/2024 19:54

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 81 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-1.40.  The mean expectation of
two analysts for the quarter was for a loss of 62 cents per
share. 
    * Revenue rose 1.9% to $3.03 million from a year ago;
analysts
expected $3.45 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 81 cents​.
    * The company reported a quarterly loss of $13 million.
    * Accelerate Diagnostics Inc shares had fallen by 74.2% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $2.00 
This summary was machine generated from LSEG data March 29 at
07:54 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.62          -0.81          Missed
 Sep. 30 2023      -1.07          0.14           Beat
 Jun. 30 2023      -1.40          -1.31          Beat
 Mar. 31 2023      -1.45          -1.70          Missed